Drug General Information
Drug ID
D0S5AL
Former ID
DCL001040
Drug Name
XTL-2125
Indication HCV infection [ICD9: 070.4, 070.5, 070.70; ICD10:B17.1, B18.2] Discontinued in Phase 1 [536646]
Company
XTL Biopharmaceutical
Target and Pathway
Target(s) RNA polymerase Target Info Modulator
KEGG Pathway Purine metabolism
Pyrimidine metabolism
Metabolic pathways
RNA polymerase
References
Ref 536646Emerging drugs for hepatitis C. Expert Opin Emerg Drugs. 2008 Mar;13(1):1-19.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.